Relapse more common than reinfection in recurrent tuberculosis 1-2 years post treatment in urban Uganda.
暂无分享,去创建一个
W. Boom | M. Joloba | K. Eisenach | M. D. Cave | A. Okwera | M. Joloba | J. Johnson | H. Mayanja-Kizza | K. Dickman | M D Cave | C. Whalen | M Joloba | C C Whalen | D. F. Johnson | D F Johnson | A Okwera | J L Johnson | H Luzze | K Dickman | H Mayanja-Kizza | K Eisenach | W H Boom | Denise F. Johnson | H. Luzze | John L. Johnson | M. Cave
[1] R. Prescott,et al. Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosis. , 1991, Respiratory medicine.
[2] J. T. Crawford,et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology , 1993, Journal of clinical microbiology.
[3] J. Paul,et al. Recurrence of HIV-related tuberculosis in an endemic area may be due to relapse or reinfection. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[4] C. Martín,et al. Use of a PCR method based on IS6110 polymorphism for typing Mycobacterium tuberculosis strains from BACTEC cultures , 1997, Journal of clinical microbiology.
[5] M. Behr,et al. Molecular fingerprinting of Mycobacterium tuberculosis: how can it help the clinician? , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] P D van Helden,et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. , 1999, The New England journal of medicine.
[7] J. Ellner,et al. Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda. , 2000, East African medical journal.
[8] D. Hom,et al. Efficacy of an unsupervised 8-month rifampicin-containing regimen for the treatment of pulmonary tuberculosis in HIV-infected adults. Uganda-Case Western Reserve University Research Collaboration. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[9] John L. Johnson,et al. Randomized Controlled Trial of Mycobacterium vaccae Immunotherapy in Non-Human Immunodeficiency Virus-Infected Ugandan Adults with Newly Diagnosed Pulmonary Tuberculosis , 2000 .
[10] P. Sonnenberg,et al. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers , 2001, The Lancet.
[11] O Afonso,et al. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. , 2001, American journal of respiratory and critical care medicine.
[12] E. Bouza,et al. Tuberculosis recurrences: reinfection plays a role in a population whose clinical/epidemiological characteristics do not favor reinfection. , 2002, Archives of internal medicine.
[13] I. Onorato,et al. An investigation of suspected exogenous reinfection in tuberculosis patients in Kampala, Uganda. , 2002, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[14] John L. Johnson,et al. Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis. , 2003, American journal of respiratory and critical care medicine.
[15] D. Guwatudde,et al. Burden of tuberculosis in Kampala, Uganda. , 2003, Bulletin of the World Health Organization.
[16] B. Metchock,et al. Recurrent tuberculosis in the United States and Canada: relapse or reinfection? , 2004, American journal of respiratory and critical care medicine.
[17] S. Ho,et al. A nested case-control study on treatment-related risk factors for early relapse of tuberculosis. , 2004, American journal of respiratory and critical care medicine.
[18] Donald A Enarson,et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. , 2005, American journal of respiratory and critical care medicine.
[19] J. Ellner,et al. Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda. , 2005, The Journal of infectious diseases.
[20] W. Boom,et al. Immune correlates of acute Mycobacterium tuberculosis infection in household contacts in Kampala, Uganda. , 2006, The American journal of tropical medicine and hygiene.
[21] J. Ellner,et al. Comparison of intermittent ethambutol with rifampicin-based regimens in HIV-infected adults with PTB, Kampala. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[22] J. Golub,et al. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[23] Pan‐Chyr Yang,et al. Prediction of the tuberculosis reinfection proportion from the local incidence. , 2007, The Journal of infectious diseases.
[24] R. Chaisson,et al. Contribution of reinfection to recurrent tuberculosis in South African gold miners. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[25] G. Marks,et al. Recurrence of tuberculosis at a Sydney chest clinic between 1994 and 2006: reactivation or reinfection? , 2008, The Medical journal of Australia.
[26] John L. Johnson,et al. Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion. , 2009, American journal of respiratory and critical care medicine.
[27] M. Joloba,et al. Detection of multiple strains of Mycobacterium tuberculosis using MIRU-VNTR in patients with pulmonary tuberculosis in Kampala, Uganda , 2010, BMC infectious diseases.
[28] D. Mitchison,et al. Timing of relapse in short-course chemotherapy trials for tuberculosis. , 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[29] A. Crampin,et al. Recurrent TB: relapse or reinfection? The effect of HIV in a general population cohort in Malawi , 2010, AIDS.
[30] D. Havlir,et al. A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4⁺ T-cell counts of ≥ 350 cells/μL. , 2011, The Journal of infectious diseases.